Agah Ramtin 4
4 · RenovoRx, Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Agah Ramtin
DirectorChief Medical Officer
Transactions
- Purchase
Common Stock
2025-12-31$0.86/sh+9,795$8,424→ 788,460 total
Footnotes (1)
- [F1]Reflects open market purchases of the Issuer's securities.